AP |
Aerobic performance |
AR |
Active recovery |
AR |
Androgen receptor |
AT |
Anaerobic threshold |
ATM |
Ataxia telangiectasia mutated |
ATP |
Adenosine triphosphate |
CAT |
Catalase |
CB1 and CB2 |
Cannabinoid receptors 1 and 2 |
CBF |
Cerebral blood flow |
CCO |
Cytochrome c oxidase |
cDNA |
Complementary DNA |
CINC-1 |
Cytokine-induced neutrophil chemoattractant-1 |
CK |
Creatine kinase |
CMJ |
Counter movement jump |
COD |
Crossover design |
CON |
Concentric |
COX-1/COX-2 |
Cyclooxygenases- 1 and -2 |
Cr |
Creatine |
CS |
Citrate synthase |
CSA |
Larger cross-sectional area |
CW |
Continuous wave |
CWI |
Cold water immersion |
DOMS |
Delayed onset muscle soreness |
ECC |
Eccentric |
GAPDH |
Glyceraldehyde-3-phosphate dehydrogenase primers |
GPCRs |
G-protein-coupled receptors |
GPx |
Glutathione peroxidase |
HFD |
High-fat diet |
HI |
Neonatal hypoxia-ischemia |
HPRT |
Hypoxanthine-guanine phosphoribosyl transferase |
HR |
Heart rate |
HRV |
Heart rate variability |
HSI |
Hamstring strain injury |
ICC |
Intra-class correlation coefficient |
IL-10 |
Interleukin 10 |
IL-1β |
Interleukin-1β |
IL-6 |
Interleukin-6 |
IMP |
Impulse |
IR |
Infrared |
iVO2MAX
|
Intensity at which VO2MAX was reached |
KET test |
Knee extension test |
La−P |
Peak lactate concentration after exercise |
LDH |
Lactate dehydrogenase |
LEDs |
Light-emitting diodes |
LEDT |
Light-emitting diode therapy |
LFD |
Low-fat diet |
MAOD |
Maximal accumulated oxygen deficit |
MAODALT |
Alternative maximal accumulated oxygen deficit |
MAP-2 |
Microtubule-associated protein-2 |
MCP-1 |
Monocyte chemoattractant protein-1 |
MDA |
Level of malondialdehyde |
MHFAKE |
Maximal hip flexion active knee extension |
MMPs |
Matrix metalloproteinases |
MOP |
Mean output power |
MPO |
Myeloperoxidase |
MRF4 |
Myogenic regulatory factor (herculin) |
MRS |
Maximum running speed |
mT |
mili Testa (magnetic field) |
mTOR |
Mammalian (or mechanistic) target of rapamycin |
MVC |
Maximum voluntary contraction |
myHC |
Myosin heavy chain |
NMES |
Neuromuscular electrical stimulation |
Nrf2 |
Nuclear factor erythroid 2-related factor 2 |
NSAIDs |
Non-steroidal anti-inflammatory drugs |
OA |
Osteoarthritis |
P200 |
Performance of 200 m |
P53 |
Tumor protein p53 |
PBMT |
Photobiomodulation therapy |
PCR |
Polymerase chain reaction |
PF |
Peak force |
PGE2 |
Prostaglandin E2 |
PNS |
Peripheral nerve stimulation |
PPO |
Peak power output |
PSLR |
Passive straight leg raise |
PV |
Peak velocity |
R |
Red |
RCT |
Double-blind randomized controlled trial |
REREX
|
Exhaustion respiratory exchange ratio |
RCTs |
Placebo-controlled randomized trials |
RPE |
Rating of perceived exertion |
RPEex |
Exhaustion perceived exertion |
SIT |
Sprint interval training |
SJ |
Squat jump |
SLR |
Straight leg raise |
sMF |
Static magnetic field |
SmO2
|
Muscle oxygen saturation |
SOD |
Superoxide dismutase |
SSC |
Stretch-shortening cycle |
TAC |
Total antioxidant capacity |
TBARS |
2-thiobarbituric acid |
TNF-α |
Tumor necrosis factor-alpha |
TRF1/TRF2 |
Telomeric repeat binding factors |
VCO2 |
Volume carbon dioxide |
VO2 |
O2 uptake |
VO2EX
|
Exhaustion oxygen consumption |
VO2MAX
|
Maximal oxygen uptake |
YYIR1 |
YoYo intermittent recovery level 1 |
1-RM |
Load in 1-repetition maximum test |
30 CJ |
30-s crossbar jump test |
↑ |
Increase |
↓ |
Decrease |